Meet Pro Pharmaceuticals Group at WHX Dubai 2026

Pro Pharmaceuticals Group will attend the World Health Expo (WHX), Dubai, from 9–12 February 2026 — our fourth consecutive participation at the region’s leading healthcare and pharmaceutical trade forum.

Our primary objective is to meet with existing suppliers and customers across the UK, USA, Canada, Europe, and India, strengthening ongoing supply relationships and advancing active sourcing and access programs.

In parallel, we will engage with GCC-based organisations involved in — or preparing for — clinical trial operations and clinical trial procurement, an area where we see rapid structural growth across the region.

Pro Pharmaceuticals Group specialises in unlicensed medicines, shortage mitigation, named-patient supply, and hospital-critical imports, supported by proven execution across regulatory pathways and controlled global logistics.

Sandip Manku (Founder & Director) and Lukasz Nowaczek (EU Operations Lead) will attend WHX to progress:

• Existing supplier and customer partnerships

• New regional sourcing opportunities

• Clinical trial supply and comparator sourcing programs

• Cross-border regulatory and logistics alignment

The Middle East continues to emerge as a strategically important healthcare and clinical trials hub, and WHX remains a key forum for advancing these collaborations.